Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shuganning (舒肝宁) is a traditional Chinese medicine injection composed of extracts from five herbs: Artemisia capillaris (茵陈), Gardenia jasminoides (栀子), Scutellaria baicalensis (黄芩), Isatis indigotica root (板蓝根), and Ganoderma lucidum (灵芝). It is used primarily for the treatment of acute and chronic liver diseases, including viral hepatitis, drug-induced liver injury, cholestatic hepatitis, cirrhosis, and hepatic failure. The formulation is based on classical TCM principles to "clear heat," detoxify the body, promote bile flow, protect hepatocytes, reduce inflammation and oxidative stress in the liver. Its mechanism involves anti-inflammatory effects and hepatoprotection through multiple pathways relevant to TCM theory[4][6][8][10].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on shuganning.